Enestia Belgium NV – FDA 483, Feb 20, 2026
ENESTIA BELGIUM NV (SHARP BELGIUM) in Hamont-Achel, Belgium, underwent an inspection of its secondary labeling and packaging operations. The FDA issued a Form 483 citing deficiencies related to the lack of routine inspection and lifecycle control for critical equipment components. Additionally, the firm failed to exercise appropriate controls over computer systems, including the use of shared user credentials and incomplete data integrity remediation for systems used in packaging and labeling.
ID · c1c8df52-e524-42b8-8c39-8dd327850c18
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.